Robert N. Taylor

ORCID: 0000-0002-1423-6351 · 131 papers in corpus
other 2024
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2024.02.004

This group was formed out of the conviction that endometriosis research has not progressed at a pace in proportion to disease severity and the negative impact on women's quality of life. Furthermore, advancement in our understanding of this…

lab-animal 2024
Cell death discovery ·doi:10.1038/s41420-024-02048-6

As the mean age of first-time mothers increases in the industrialized world, inquiries into causes of human reproductive senescence have followed. Rates of ovulatory dysfunction and oocyte aneuploidy parallel chronological age, but poor rep…

lab-animal 2023
The American Journal of Pathology ·doi:10.1016/j.ajpath.2023.04.007

Pelvic pain in women with endometriosis is attributed to neuroinflammation and afferent nociceptor nerves in ectopic and eutopic endometrium. The hypothesis that uterine nociception is activated by IL-1β, a prominent cytokine in endometrios…

lab-animal 2023
Research square ·doi:10.21203/rs.3.rs-2870585/v1

Endometriosis is a common gynecological inflammatory disorder characterized by immune system dysregulation, which is involved in lesion initiation and progression. Studies have demonstrated that several cytokines are associated with the evo…

lab-animal 2023
Inflammation ·doi:10.1007/s10753-023-01862-x

Endometriosis is a common gynecological inflammatory disorder characterized by immune system dysregulation, which is involved in lesion initiation and progression. Studies have demonstrated that several cytokines are associated with the evo…

other 2022
Reproduction & fertility ·doi:10.1530/raf-22-0041

IN VITRO: culturing of endometrial cells obtained from the uterine mucosa or ectopic sites is used to study molecular and cellular signalling relevant to physiologic and pathologic reproductive conditions. However, the lack of consensus on …

lab-animal 2022
·doi:10.1210/jendso/bvac150.1475

Abstract Endometriosis is a common gynecological inflammatory disorder, which is characterized by immune system dysregulation with initiation and progression. It affects 5% to 15% of reproductive-age women and is present in as many as 30% t…

lab-animal 2021
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgab511

CONTEXT: Human embryonic implantation is regulated by neuroendocrine hormones, ovarian steroids, growth factors, and cytokines. Sympathetic innervation of the uterus also may play a role. OBJECTIVE: We tested the hypothesis that cabergolin…

review 2020
The journal of obstetrics and gynaecology research ·doi:10.1111/jog.14262

Fine-tuning of the endometrium during the evanescent 'window of implantation' relies upon an array of diverse and redundant signaling molecules, particularly the ovarian steroids E2 and P4, but also growth factors, eicosanoids, and vitamins…

observational 2020
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2020.01.002

STUDY OBJECTIVE: Prior research has collectively shown that endometriosis is inversely related to women's adiposity. The aim of this study was to assess whether this inverse relationship holds true by disease severity and typology. DESIGN:…

2020
·doi:10.1007/978-3-030-39903-0_14
2020
·doi:10.1007/978-3-030-57866-4
lab-animal 2020
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgaa413

CONTEXT: Implantation is a reproductive bottleneck in women, regulated by fluctuations in ovarian steroid hormone concentrations. However, other nuclear receptor ligands are modifiers of endometrial differentiation leading to successful pre…

rct 2020
·doi:10.1097/01.aog.0000663180.46470.c9

INTRODUCTION: Linzagolix is a new, investigational, non-peptide, GnRH receptor antagonist being developed to treat endometriosis-associated pain (EAP). The EDELWEISS trial was a Phase 2b, double-blind, randomized, placebo-controlled, multic…

2020
·doi:10.1007/978-3-030-57866-4_4
lab-animal 2020
·doi:10.1210/jendso/bvaa046.668

Abstract Endometriosis and uterine fibroids (leiomyomas) are benign gynecological disorders affecting 5-15% of women of reproductive age. They cause a wide range of symptoms including mild to severe pelvic pain and infertility. Due to a pau…

rct 2020
·doi:10.1097/01.aog.0000663200.75027.38

INTRODUCTION: Linzagolix is a new investigational, non-peptide, oral GnRH receptor antagonist being developed to treat endometriosis-associated pain (EAP). The EDELWEISS trial was a Phase 2b, double-blind, randomized, placebo-controlled, mu…

rct 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.02.114

OBJECTIVE: To study the effect of a new investigational oral gonadotropin-releasing hormone antagonist, linzagolix, on endometriosis-associated pain (EAP). DESIGN: A multinational, parallel group, randomized, placebo-controlled, double-bli…

review 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2019.02.033

Endometriosis, a systemic disease that is often painful and chronic, affects ∼10% of reproductive-age women. The disease can have a negative impact on a patient's physical and emotional well-being, quality of life, and productivity. Endomet…

observational 2019
Frontiers in pediatrics ·doi:10.3389/fped.2019.00195

Background: Endometriosis (EM) is a recognized co-morbid condition in women with chronic fatigue syndrome (CFS). This analysis evaluates the impact of EM on the health of women with CFS by comparing selected health characteristics and labor…

lab-animal 2019
Molecular human reproduction ·doi:10.1093/molehr/gaz045

Human blastocyst nidation in the uterus and successful pregnancy require coordinated endometrial expression of estrogen receptor (ER)-α, progesterone receptors (PR)-A and -B and the gap junction protein, connexin (Cx)43. Our prior work esta…

2019
·doi:10.1016/j.fertnstert.2019.07.935
lab-animal 2019
·doi:10.1210/js.2019-sat-200

Endometriosis is a chronic gynecological inflammatory disorder in which immune system dysregulation is thought to play a role in its initiation and progression. Current agency-approved hormonal therapies, including synthetic progestins, GnR…

review 2018
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.12521

Challenges intrinsic to the accurate diagnosis of endometriosis contribute to an extended delay between the onset of symptoms and clinical confirmation. Intraoperative visualization, preferably with histologic verification, is considered by…

2018
·doi:10.2174/1573404813666170614122110

Background: Endometriosis is characteristically defined as the presence of endometrial glands and stroma outside the uterine cavity. Despite an estimated prevalence of 10% in women, the specific etiology, molecular, and clinical aspects of …